Marius Horger
YOU?
Author Swipe
View article: Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma
Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma Open
This multicenter imaging study aimed to establish and validate automated radiomics models predicting therapy response (TR) and minimal residual response (MRD) in newly diagnosed multiple myeloma (MM) from baseline MRI. Retrospectively, 118…
View article: Imaging of Pathologies of the Temporal Bone and Middle Ear: Inflammatory Diseases, Their Mimics and Potential Complications—Pictorial Review
Imaging of Pathologies of the Temporal Bone and Middle Ear: Inflammatory Diseases, Their Mimics and Potential Complications—Pictorial Review Open
Imaging of the temporal bone and middle ear is challenging for radiologists due to the abundance of distinct anatomical structures and the plethora of possible pathologies. The basis for a precise diagnosis is knowledge of the underlying a…
View article: A novel fully automated method for measuring ASPECTS to improve stroke diagnosis: Comparison to traditional ASPECTS
A novel fully automated method for measuring ASPECTS to improve stroke diagnosis: Comparison to traditional ASPECTS Open
Background and Purpose To compare the accuracy of subjective Alberta Stroke Program Early CT Score (sASPECTS) evaluation and that of an automated prototype software (aASPECTS) on nonenhanced CT (NECT) in patients with early anterior territ…
View article: Photon-counting computed tomography – clinical application in oncological, cardiovascular, and pediatric radiology
Photon-counting computed tomography – clinical application in oncological, cardiovascular, and pediatric radiology Open
Background Photon-counting detector computed tomography (PCD-CT) is a promising new technology with the potential to fundamentally change workflows in the daily routine and provide new quantitative imaging information to improve clinical d…
View article: Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report
Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report Open
Myasthenia gravis (MG) is a heterogeneous autoimmune disease, which is characterized by a postsynaptic neuromuscular transmission defect, with antibodies directly targeting the acetylcholine receptor (AChR) or other structural proteins of …
View article: Automated Intracranial Clot Detection: A Promising Tool for Vascular Occlusion Detection in Non-Enhanced CT
Automated Intracranial Clot Detection: A Promising Tool for Vascular Occlusion Detection in Non-Enhanced CT Open
(1) Background: to test the diagnostic performance of a fully convolutional neural network-based software prototype for clot detection in intracranial arteries using non-enhanced computed tomography (NECT) imaging data. (2) Methods: we ret…
View article: CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome Open
Importance Autoimmune disorders can affect various organs and if refractory, can be life threatening. Recently, CD19-targeting–chimeric antigen receptor (CAR) T cells were efficacious as an immune suppressive agent in 6 patients with refra…
View article: Is There Still a Role for Two-Phase Contrast-Enhanced CT and Virtual Monoenergetic Images in the Era of Photon-Counting Detector CT?
Is There Still a Role for Two-Phase Contrast-Enhanced CT and Virtual Monoenergetic Images in the Era of Photon-Counting Detector CT? Open
Background: To compare the diagnostic characteristics between arterial phase imaging versus portal venous phase imaging, applying polychromatic T3D images and low keV virtual monochromatic images using a 1st generation photon-counting CT d…
View article: Supplementary Figure S3 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Figure S3 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Figure S3 illustrates genomic breakpoints of fusions in KRASwt tumors.
View article: Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
We used whole-genome and transcriptome sequencing to identify clinically actionable genomic alterations in young adults with pancreatic ductal adenocarcinoma (PDAC). Molecular characterization of 17 patients with PDAC enrolled in a precisi…
View article: Supplementary Figure S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Figure S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Figure S2 shows experimental data demonstrating the proliferative capacity of the ATP1B1-NRG1 fusion.
View article: Supplementary Figure S3 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Figure S3 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Figure S3 illustrates genomic breakpoints of fusions in KRASwt tumors.
View article: Supplementary Table S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Table S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Table S1 lists potentially clinically relevant somatic alterations in the PDAC patient cohort.
View article: Supplementary Table S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Table S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Table S2 shows sequencing coverage metrics.
View article: Supplementary Patient Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Patient Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary patient data provides a summary on the clinical course of patient 16.
View article: Supplementary Table S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Table S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Table S1 lists potentially clinically relevant somatic alterations in the PDAC patient cohort.
View article: Supplementary Figure S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Figure S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Figure S2 shows experimental data demonstrating the proliferative capacity of the ATP1B1-NRG1 fusion.
View article: Supplementary Figure S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Figure S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Figure S1 shows circos plots including 17 PDACs of the patient cohort and a PDCM.
View article: Supplementary Figure S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Figure S1 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Figure S1 shows circos plots including 17 PDACs of the patient cohort and a PDCM.
View article: Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
We used whole-genome and transcriptome sequencing to identify clinically actionable genomic alterations in young adults with pancreatic ductal adenocarcinoma (PDAC). Molecular characterization of 17 patients with PDAC enrolled in a precisi…
View article: Supplementary Table S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Table S2 from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary Table S2 shows sequencing coverage metrics.
View article: Supplementary Patient Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
Supplementary Patient Data from <i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer Open
Supplementary patient data provides a summary on the clinical course of patient 16.
View article: Photon-Counting Computed Tomography – Basic Principles, Potenzial Benefits, and Initial Clinical Experience
Photon-Counting Computed Tomography – Basic Principles, Potenzial Benefits, and Initial Clinical Experience Open
Background Photon-counting computed tomography (PCCT) is a promising new technology with the potential to fundamentally change today’s workflows in the daily routine and to provide new quantitative imaging information to improve clinical d…
View article: THE MOLECULAR INTERACTION PATTERN OF LENVATINIB ENABLES INHIBITION OF WILD-TYPE OR KINASE-MUTATED FGFR2-DRIVEN CHOLANGIOCARCINOMA
THE MOLECULAR INTERACTION PATTERN OF LENVATINIB ENABLES INHIBITION OF WILD-TYPE OR KINASE-MUTATED FGFR2-DRIVEN CHOLANGIOCARCINOMA Open
Enclosed are the molecular dynamics simulations of drug–FGFR2 systems and the MM-GBSA raw data. The zip archives include the molecular dynamics trajectory files in Desmond Maestro format (*_trj; *-out.cms), the naming of zip archives is as…
View article: Myeloma bone disease imaging on a 1st-generation clinical photon-counting detector CT vs. 2nd-generation dual-source dual-energy CT
Myeloma bone disease imaging on a 1st-generation clinical photon-counting detector CT vs. 2nd-generation dual-source dual-energy CT Open
Objective Subjective and objective image quality comparison of bone microstructure and disease-related abnormalities in multiple myeloma patients using a 1st-generation dual-source photon-counting detector CT(DS-PCD-CT) and a 2nd-generatio…
View article: Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma Open
NUT carcinoma (NC) is a rare and extremely aggressive form of cancer, usually presenting with intrathoracic or neck manifestations in adolescents and young adults. With no established standard therapy regimen and a median overall survival …
View article: NUT Carcinoma—An Underdiagnosed Malignancy
NUT Carcinoma—An Underdiagnosed Malignancy Open
NUT carcinoma (NC) is a rare and highly aggressive malignancy with a dismal prognosis and a median survival of 6–9 months only. Although very few cases of NC are reported each year, the true prevalence is estimated to be much higher, with …
View article: Antibody-Guided Molecular Imaging of <i>Aspergillus</i> Lung Infections in Leukemia Patients
Antibody-Guided Molecular Imaging of <i>Aspergillus</i> Lung Infections in Leukemia Patients Open
This is the author accepted manuscript. The final version is available from the Society of Nuclear Medicine via the DOI in this record
View article: Dual-Energy Computed Tomography-Based Quantitative Bone Marrow Imaging in Non-Hematooncological Subjects: Associations with Age, Gender and Other Variables
Dual-Energy Computed Tomography-Based Quantitative Bone Marrow Imaging in Non-Hematooncological Subjects: Associations with Age, Gender and Other Variables Open
Background: Our aim is to assess the utility and associations of quantitative bone marrow attenuation (BMA) values measured on clinical dual-energy computed tomography (DECT) exams in non-hematooncologic subjects with skeletal regions, pat…